COVID-19 vaccine deliberation in individuals directly impacted by incarceration

Delays in vaccinating communities of color to COVID-19 have signaled a need to investigate structural barriers to vaccine uptake, with mass incarceration demanding greater characterization as a potential factor. In a nationally representative survey from February-March 2021 (N = 1,157), exposure to the criminal legal system, defined as having been incarcerated in prison or jail…

Read More

Modeling the impact of spatial inequities in access to medications for treatment of opioid use disorder among persons who inject drugs

Actual (real-world) and counterfactual scenarios of varying levels of social and spatial inequity to providers of methadone were evaluated using HepCEP, a validated agent-based model of syringe sharing behaviors among people who inject drugs (PWID) in metropolitan Chicago, Illinois, U.S.A. Synthetic spatial distributions reflecting disparate geographic patterns of methadone provider location and population characteristics are…

Read More

A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated

People with opioid use disorder (OUD) are overrepresented in US correctional facilities and experience disproportionately high risk for illicit opioid use and overdose after release. A growing number of correctional facilities offer medication for OUD (MOUD), which is effective in reducing these risks. However, a recent evaluation found that <50% of those prescribed MOUD during…

Read More

COVID-19 vaccination in correctional systems in the United States

Overcrowding and limited ability to social distance contribute to high rates of COVID-19 outbreaks in correctional facilities. Despite CDC recommendations, incarcerated persons and correctional staff report a high prevalence of vaccine-hesitance. We sought to identify reasons underlying COVID-19 vaccine hesitation and refusal in correctional systems. We searched PubMed abstracts and reviewed literature relevant to COVID-19…

Read More

Collaboration and growth in a large research cooperative: A network analytic approach

Research networks encourage team science and facilitate collaboration within and across research teams. While many analyses have examined the output of these collaborative networks (e.g., authorship networks, publications, grant applications), less attention has been paid to the formative phases of these initiatives. This article presents analyses of a whole-network survey of investigators participating in a…

Read More

Access to services for pregnant people with OUD in jails in the US

The aim of this study is to assess the availability of medications for opioid use disorder (MOUD) and other services for pregnant people in jails in counties heavily impacted by opioid overdose in the U.S. Most jails in the study sample (84.5%) have MOUD available for pregnant people, however, less than half of these jails…

Read More

JCOIN Webinar: Xylazine Prevalence and Response Strategies

Xylazine is a non-opioid sedative not approved for human use that is increasingly found as an adulterant in the illicit drug supply. Researchers, public health officials, and community leaders are working to address xylazine in prevention, clinical care, and overdose prevention. Panelists will discuss the prevalence and toxicology of xylazine, overdose response strategies, and what…

Read More